Neoadjuvant PD-L1/TGF-β blockade can rapidly disrupt the tumor stroma in head and neck cancer patients
- DOI
- 10.1172/jci198718
- Published
- 2026-11-02
- Container
- Journal of Clinical Investigation
- Publisher
- American Society for Clinical Investigation
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1172/jci198718,
title = {Neoadjuvant PD-L1/TGF-β blockade can rapidly disrupt the tumor stroma in head and neck cancer patients},
author = {Caroline Hoffmann and Jan-Timon Werle and Philémon Sirven and Mamy Andrianteranagna and Jocelyn Gal and Wiem Lassoued and Jerzy Klijanienko and Jeremy Mesple and Benjamin Demaille and Abdenour Abbas and Valentine Gauthier and Kyra J.E. Borgman and Isabelle Puisieux and Serena Janho dit Hreich and Olivier Choussy and Gregoire Marret and Sonia Lameiras and Nathalie Badois and Antoine Dubray-Vautrin and Gilles Dolivet and Lionnel Geoffrois and Renaud Leclère and Wail Zeitouni and Noemie Robil and Jane Merlevede and Altynbek Zhubanchaliyev and Maud Kamal and Ivan Bieche and Laure Monard and Clotilde Simon and Delphine Louis and Clint T. Allen and Arun Rajan and James L. Gulley and Maude Guillot-Delost and Christophe Le Tourneau and Hélène Salmon},
year = {2026},
journal = {Journal of Clinical Investigation},
doi = {10.1172/jci198718},
url = {https://doi.org/10.1172/jci198718}
}RIS
TY - JOUR TI - Neoadjuvant PD-L1/TGF-β blockade can rapidly disrupt the tumor stroma in head and neck cancer patients AU - Caroline Hoffmann AU - Jan-Timon Werle AU - Philémon Sirven AU - Mamy Andrianteranagna AU - Jocelyn Gal AU - Wiem Lassoued AU - Jerzy Klijanienko AU - Jeremy Mesple AU - Benjamin Demaille AU - Abdenour Abbas AU - Valentine Gauthier AU - Kyra J.E. Borgman AU - Isabelle Puisieux AU - Serena Janho dit Hreich AU - Olivier Choussy AU - Gregoire Marret AU - Sonia Lameiras AU - Nathalie Badois AU - Antoine Dubray-Vautrin AU - Gilles Dolivet AU - Lionnel Geoffrois AU - Renaud Leclère AU - Wail Zeitouni AU - Noemie Robil AU - Jane Merlevede AU - Altynbek Zhubanchaliyev AU - Maud Kamal AU - Ivan Bieche AU - Laure Monard AU - Clotilde Simon AU - Delphine Louis AU - Clint T. Allen AU - Arun Rajan AU - James L. Gulley AU - Maude Guillot-Delost AU - Christophe Le Tourneau AU - Hélène Salmon PY - 2026 JO - Journal of Clinical Investigation DO - 10.1172/jci198718 UR - https://doi.org/10.1172/jci198718 ER -
APA
Hoffmann, C., Werle, J., Sirven, P., Andrianteranagna, M., Gal, J., Lassoued, W., Klijanienko, J., Mesple, J., Demaille, B., Abbas, A., Gauthier, V., Borgman, K. J., Puisieux, I., Hreich, S. J. D., Choussy, O., Marret, G., Lameiras, S., Badois, N., Dubray-Vautrin, A., Dolivet, G., Geoffrois, L., Leclère, R., Zeitouni, W., Robil, N., Merlevede, J., Zhubanchaliyev, A., Kamal, M., Bieche, I., Monard, L., Simon, C., Louis, D., Allen, C. T., Rajan, A., Gulley, J. L., Guillot-Delost, M., Tourneau, C. L., & Salmon, H. (2026). Neoadjuvant PD-L1/TGF-β blockade can rapidly disrupt the tumor stroma in head and neck cancer patients. Journal of Clinical Investigation. https://doi.org/10.1172/jci198718
Source records
- crossref · retrieved 2026-11-04T10:31:17.320Z